Skip to content

Physiological markers of Trauma-related nightmares among military personnel suffering from PTSD: A multicenter home-recording study.

Psychiatry and Clinical Neurosciences February 14, 2026 DOI: 10.1111/pcn.70038 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational cohort (case-crossover matched analysis) Peer reviewed
Sample size 168
Population Military participants: 60 healthy controls, 34 PTSD patients without TRNs, and 74 PTSD patients with TRNs, from the SOMMEPT cohort
Duration Pre-awakening autonomic activity analyzed over 10 minutes; post-awakening reactivity over a 2-minute window
Measures Electroencephalography (EEG), electrodermal activity (EDA), heart rate variability, motor activity
Topics Dreaming PTSD
Registration NCT04581850
Key findings Trauma-related nightmares were associated with a distinctive autonomic pattern: pre-awakening sudomotor buildup (heightened electrodermal activity, earlier peaks, prolonged recovery) and reduced vagal heart rate variability compared with spontaneous awakenings in healthy controls, with weaker differences versus PTSD patients without TRNs or non-TRN awakenings. Post-awakening, TRNs elicited an abrupt surge in heart rate (accelerating within about 40 seconds and normalizing by about 2 minutes), sustained tonic electrodermal activity, longer phasic bursts, and increased motor activity during the first roughly 80 seconds. The authors argue these findings support biomarker-based detection and targeted intervention.

Abstract

Aim: Despite being one of the most disabling symptoms of post‐traumatic stress disorder (PTSD)—disrupting sleep continuity, reinforcing hyperarousal, and worsening psychiatric comorbidity—the physiological signature of Trauma‐related nightmares (TRNs) under naturalistic sleep conditions remains poorly characterized.

Methods: We used home‐based, multi‐sensor devices from the SOMMEPT cohort to assess whether TRNs display distinct autonomic dynamics before and after awakening. TRN awakenings were self‐marked with the wristband button and validated through electroencephalography (EEG) inspection by a psychiatrist and a sleep physician. Each TRN event ( N = 412) was matched 1:1 to three control conditions: spontaneous awakenings in 60 healthy military participants, awakenings in 34 military PTSD patients without TRNs, and non‐nightmare awakenings from 74 military PTSD patients with TRNs. Pre‐awakening autonomic activity was analyzed over 10 min, and post‐awakening reactivity over a 2‐min window using nonparametric statistics with cluster‐based permutation correction.

Results: TRNs were associated with heightened sudomotor activity and reduced vagal heart rate variability compared with spontaneous awakenings in healthy controls; differences were weaker versus PTSD patients without TRNs or non‐TRN awakenings. Phasic Electrodermal activity (EDA) showed earlier peaks and prolonged recovery, while movement was lower before TRN‐related awakenings. Post‐awakening, TRNs elicited an abrupt surge: heart rate accelerated within ~40 s and normalized by ~2 min; tonic EDA remained elevated, phasic EDA bursts were longer, slower to recover, and motor activity rose during the first ~80 s.

Conclusions: TRNs display a distinctive autonomic pattern with pre‐awakening sudomotor buildup and post‐awakening cardiovascular–electrodermal surges, supporting biomarker‐based detection and targeted intervention.

Trial Registration: ClinicalTrials.gov Identifier: NCT04581850.

Comparable studies

Other randomized controlled trials on PTSD, most cited first.

Study Year Design Participants
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Patients with severe PTSD, including those with comorbidities such as dissociation,... 2021 Randomized controlled trial n = 90
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Patients with chronic post-traumatic stress disorder refractory to both psychotherapy... 2010 Randomized controlled trial n = 20
Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder Patients with chronic PTSD related to a range of trauma exposures 2014 Randomized controlled trial n = 41
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Military veterans and first responders aged 18 or older with chronic PTSD lasting 6... 2018 Randomized, double-blind, dose-response, phase 2 clinical trial n = 26
A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD) Patients with treatment-resistant PTSD 2012 Randomized controlled trial n = 12

Citations in the library

Explore topics